Equasens Société anonyme (EPA:EQS)

Market Cap	472.76M -30.1%
Revenue (ttm)	236.52M +9.1%
Net Income	39.33M +8.6%
EPS	2.62 +9.6%
Shares Out	15.03M
PE Ratio	12.02
Forward PE	10.71
Dividend	1.40 (4.31%)
Ex-Dividend Date	Jul 1, 2026

Volume	16,928
Open	31.30
Previous Close	31.45
Day's Range	31.10 - 31.85
52-Week Range	30.85 - 46.70
Beta	0.56
Analysts	Strong Buy
Price Target	54.68 (+75.54%)
Earnings Date	Sep 28, 2026

About Equasens Société anonyme

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; distribution of computer equipment, turnkey installation and training; afte...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1996
• Employees: 1,462
• Stock Exchange: Euronext Paris
• Ticker Symbol: EQS

Financial Performance

In 2025, Equasens Société anonyme's revenue was 236.52 million, an increase of 9.12% compared to the previous year's 216.75 million. Earnings were 39.33 million, an increase of 8.55%.

Analyst Summary

According to 4 analysts, the average rating for EQS stock is "Strong Buy." The 12-month stock price target is €54.68, which is an increase of 75.54% from the latest price.

Price Target

€54.68

(75.54% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error